ENVISION HEALTH TECHNOLOGIES INC
Fully automated adaptive perimetry software for early detection and monitoring of glaucoma-related visual field defects
- Sector
- Medtech
- Headquarters
- BROOKLYN, NY
- Founded
- 2022
- Latest Form D
- $1.6M, Oct 2025
- Total capital
- $1.9M
- Federal grants
- $275K
- 1 award · 2024
- Rank in peer group#15 of 50
- Private capital raised
- $1.6M
- 1 Form D · last Oct 2025
- 13 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 7 pending · first 2026
- Rank in peer group#11 of 50
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$1.6M
- Federal grantNSF · Phase I · SBIR Phase I: ADAPTIVE PERIMETRY FOR HEAD MOUNTED DEVICES$275K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
15months
from ENVISION HEALTH TECHNOLOGIES INC’s first federal award to its first private round.
- First federal award · Jul 2024
- NSF · $275K
- First Form D · Oct 2025
- $1.6M · 1st Form D
- Awards before first raise
- 1 award
An association in public records, not a cause or a prediction.
Standing among 50 peers
Line = medianMedtech · Software
- Federal grants#15 · top 30%
- Granted patents#11 · top 22%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Lama Al-AswadExecutive OfficerNamed in SEC Form D filings
- Ridwan ShabsighDirectorNamed in SEC Form D filings
What it has protected
USPTO · 1 granted of 8- New patentVisual Field systems and methods for glaucoma diagnosis and monitoring by implementing adaptive map perimetry via head-mounted displaysUSPTOUS 12,758,093
- PendingVisual Field systems and methods for glaucoma diagnosis and monitoring by implementing adaptive map perimetry via head-mounted displaysUSPTOApplication 19410291
- PendingVisual Field systems and methods for glaucoma diagnosis and monitoring by implementing adaptive map perimetry via head-mounted displaysUSPTOApplication 19410281
Show all 8 patent records
- Visual Field systems and methods for glaucoma diagnosis and monitoring by implementing adaptive map perimetry via head-mounted displaysOct 13, 2026 · US 12,758,093Granted
- Visual Field systems and methods for glaucoma diagnosis and monitoring by implementing adaptive map perimetry via head-mounted displaysMar 26, 2026 · Application 19410291Pending
- Visual Field systems and methods for glaucoma diagnosis and monitoring by implementing adaptive map perimetry via head-mounted displaysMar 26, 2026 · Application 19410281Pending
- Visual Field Systems And Methods For Glaucoma Diagnosis And Monitoring By Implementing Adaptive Map Perimetry Via Head-mounted DisplaysApplication PCTUS2024062110Pending
- Visual Field Systems And Methods For Glaucoma Diagnosis And Monitoring By Implementing Adaptive Map Perimetry Via Head-mounted DisplaysApplication PCTUS2024062108Pending
- Visual Field Systems And Methods For Glaucoma Diagnosis And Monitoring By Implementing Adaptive Map Perimetry Via Head-mounted DisplaysApplication 63673383Pending
- Visual Field Systems And Methods For Glaucoma Diagnosis And Monitoring By Implementing Adaptive Map Perimetry Via Head-mounted DisplaysApplication 63615945Pending
- Visual Field Systems And Methods For Glaucoma Diagnosis And Monitoring By Implementing Adaptive Map Perimetry Via Head-mounted DisplaysApplication PCTUS2024062113Pending
Related companies, and why
- SolvingDynamics, Inc.Similar federal contract value in Medtech · null in contracts
- Eysz, Inc.Similar federal contract value in Medtech · null in contracts
- Clara Biotech, Inc.Similar federal contract value in Medtech · null in contracts
- Liberate Medical LLCSimilar federal contract value in Medtech · null in contracts
- Bloomlife, Inc.Similar federal contract value in Medtech · null in contracts
- COLOWRAP, LLCSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .